Skip to content
Review Open access

Pesticide Exposure and Gynecological Cancers: A Review of Epidemiological Evidence and Mechanistic Pathways

Jul 2026 · Diseases · Vol 14 · 0 citations · 50 references
Medicine

TL;DR

Overall, pesticide exposure is a significant factor in the development and progression of women’s cancers, although the strength of the evidence varies across pesticide classes.

Abstract

Environmental exposure to pesticides is considered a risk factor for gynecological cancers, contributing to their onset and progression through various mechanisms. This narrative review investigates the role of different pesticides in the development and progression of ovarian, endometrial, and cervical cancers, and provides a comprehensive synthesis of epidemiological findings along with molecular mechanisms, highlighting carcinogenic pathways, conflicting findings, and potential therapeutic implications. Relevant epidemiological and experimental studies published between 2000 and 2025 were identified through searches of major scientific databases. Various pesticides, particularly organochlorines, contribute to gynecological cancers through mechanisms such as estrogen mimicry, DNA damage, oxidative stress, increased pro-inflammatory cytokines, and disruption of cellular signaling pathways. However, most studies found no significant association between certain pesticides, such as Triazines and Atrazine, and gynecological cancers. Furthermore, some pesticides, like Carbendazim, exhibit a dual role; while carcinogenic, they can also serve therapeutic purposes in cancer treatment when utilized with nanotechnology. Overall, pesticide exposure is a significant factor in the development and progression of women’s cancers, although the strength of the evidence varies across pesticide classes. Despite numerous studies, contradictory findings necessitate further research to clarify causal relationships.

Read PDF

Similar papers

Review Open access Aug 2026

Bisphenol A and ovarian cancer: emerging evidence and potential biological mechanisms

Overall, evidence linking BPA exposure to ovarian-cancer-related outcomes remains limited, and current findings do not establish that BPA causes OC or worsens patient prognosis in humans.

Lu-Lu Zhang, Tong Yu, Zhong-Liu Bian et al. · 0 citations
Review Open access Aug 2026

Current Evidence Linking Microplastic Exposure and Reproductive Cancers

Current evidence supports the biological plausibility of an association between microplastic exposure and reproductive cancer-related processes, while highlighting the need for standardized methodologies and well-designed longitudinal human studies to clarify potential health risks.

B. Rais, A. Vafa, Faten F. Bin Dayel et al. · 0 citations
Review Open access Aug 2026

Vitamin D₃ in cancer prevention and therapy: molecular mechanisms, clinical evidence, and future perspectives

Current evidence supports vitamin D₃ as a safe, cost-effective, and promising adjuvant strategy in oncology; however, its routine clinical application requires validation through well-designed, large-scale randomized controlled trials to establish optimal dosing strategies, identify responsive patient populations, and...

S. Khan, Sumbul Saeed, Hajer N. Sheikh et al. · 0 citations
Review Open access Aug 2026

Occupational Medicine In The Prevention And Management Of Workplace Related Cancer: Mechanisms, Strategies And Emerging Challenges

The role of occupational medicine in identifying, managing, and preventing cancers linked to workplace exposures, while addressing diagnostic advances, regulatory frameworks, and preventive strategies is examined.

Dhanya Boopathe, Kamalesh V · 0 citations
Review Open access Aug 2026

Environmental Genotoxins and Human Health Risks: Exposure Pathways, Mechanisms, Biomarkers and Challenges for Causal Risk Assessment

This critical narrative review integrates evidence on major environmental genotoxin classes, exposure routes, molecular mechanisms, human biomonitoring, disease associations and risk-assessment practice for well-established and less mature evidence domains.

Omoighele F. Akhigbe, O. Abutu, N. Y. Wike et al. · 0 citations
Review Open access Aug 2026

Medical Cannabis and the Hallmarks of Cancer: A Critical Narrative Review

Overall, cannabinoids exhibit biologically plausible antitumour activity across multiple cancer hallmarks and may present promising candidates for combination therapeutic strategies, although the current evidence remains predominantly preclinical, and robust translational studies and clinical trials are needed.

Diana Russo, Rute Fernandes, Valéria Tavares et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.